Inactivation of the purified bovine μ opioid receptor by sulfhydryl reagents

Neurochemical Research

Volumn 24, Issue 1, 1999, Pages 37-42

  Gioannini, Theresa L ^a   Onoprishvili, Irma ^b   Hiller, Jacob M ^b   Simon, Eric J ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cysteine; Purified opioid receptor; Sulfhydryl reagent

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); BREMAZOCINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; METHYLAMINE; MU OPIATE RECEPTOR; NALOXONE; THIOL REAGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CATTLE; CHIMERA; CONTROLLED STUDY; DRUG INACTIVATION; DRUG RECEPTOR BINDING; LIGAND BINDING; MOLECULAR CLONING; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN PURIFICATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; BENZOMORPHANS; CATTLE; CELL MEMBRANE; CORPUS STRIATUM; CYSTEINE; DITHIONITROBENZOIC ACID; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALINS; ETHYLMALEIMIDE; KINETICS; LIGANDS; NALOXONE; RADIOLIGAND ASSAY; RECEPTORS, OPIOID, MU; SULFHYDRYL REAGENTS; TRITIUM;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0032926537     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020923928936     Document Type: Article

References (29)

1. Minami, M. and Satoh, M. 1995. Molecular biology of the opioid receptors: structure, functions, and distributions. Neuroscience Research 23:121-45.
2. Knapp, R. A., Malatynska, E., Collins, N., Fang, L., Wang, J. Y., Hruby, V. J., Roeske, W. R., and Yamaura, H. I. 1995. Molecular Biology and pharmacology of cloned opioid receptors. FASEB J. 9:516-25.
3. Meng, F., Hoversten, M. T., Thompson, R. C., Taylor, L., Watson, S. J., and Akil, H. 1995. A chimeric study of the molecular basis of affinity and selectivity of the κ and δ opioid receptors potential role of extracellular domains. J. Biol. Chem. 270:12730-2736.
4. Surratt, C. K., Johnson, P. S., Moriwaki, A., Seidleck, B. K., Blaschak, C. J., Wang, J. B., and Uhl, G. R. 1994. Mu opiate receptor: charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269: 20548-0553.
5. Befort, K., Tabbara, L., Bausch, S., Chavkin, C., Evans, C. J., and Kieffer, B. L. 1996. The conserved aspartate residue in the third putative transmembrane domain of the 6 opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site. Mol. Pharmacol. 49:216-23.
6. Wang, W. W., Shahrestanifar, Jin, J., and Howells, R. D. 1995. Studies on μ and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc. Natl. Acad. Sci. 92:12436-12440.
7. Kong, H., Raynor, K., Yasuda, K., Moe, S. T., Portoghese, P. S., Bell, G. I., and Reisine, T. 1993. A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268:23055-3058.
8. Ehrlich, G. K., Andria, M. L., Zheng, X., Kieffer, B., Gioannini, T. L., Hiller, J. M., Rosenkranz, J. E., Veksler, B. M., Zukin, R. S., and Simon, E. J. 1998. Functional significance of cysteine residues in the δ opioid receptor studied by site-directed mutagenesis. Canadian J. of Physiol. and Pharmacol. 76:269-277.
9. 3H-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. USA 70:1947-949.
10. Pasternak, G. W., Wilson, H. A., and Snyder, S. H. 1975. Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists. Mol. Pharmacol. 11:340-51.
11. Simon, E. J., and Groth, J. 1975 Kinetics of opiate receptor inactivation by sulfhydryl reagents: evidence for conformational change in presence of sodium ions. Proc. Natl. Acad. Sci. USA 72:2404-407.
12. Ofri, D. and Simon, E. J. 1992. Sulfhydryl groups on opioid receptors revisited: Evidence for two sulfhydryl groups at or near the active site of the mu opioid receptor. Receptor 2:109-19.
13. Means, G. E., and Feeney, R. E. 1971 pp. 110-14 in The Chemical Modification of Proteins, Holden-Day, San Francisco, CA.
14. Mulliken-Kilpatrick, D., Larsen, N. E., and Blume, J. J. 1983. Protection of opiate receptors in NG108-15 cells against modification by N-ethylmaleimide. J. Neurosci. 3:145-52.
15. 3H-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. USA 70:1947-1949.
16. Gioannini, T. L., Howard, A. D., Hiller, J. M., and Simon, E. J. 1985. Purification of an active opioid binding protein from bovine striatum. J. Biol. Chem. 260:15117-15121.
17. Fan, L.-Q., Gioannini, T. L., Wolinski, T., and Simon, E. J. 1995. Functional reconstitution of a highly purified μ-opioid binding protein with purified G-proteins in liposomes. J of Neurochem. 65:2537-542.
18. Gioannini, T. L., Fan, L.-Q., Hyde, L., Ofri, D., Yao, Y. -H., Hiller, J. M., and Simon, E. J. 1993. Reconstitution of a purified mu-opioid binding protein in liposomes: Selective, high affinity, GTPγS-sensitive mu-opioid agonist binding is restored. Biochem. Biophys. Res. Comm. 194:901-908.
19. Lundblad, R. L. 1995. The modification of cysteine. Pages 63-89, in Techniques in Protein Modification. CRC Press, Boca Raton, F1.
20. Ofri, D., Ritter, A. M., Liu, Y., Gioannini, T. L., Hiller, J. M., and Simon, E. J. 1992. Characterization of CHAPS-solubilized opioid receptors: Reconstitution and uncoupling of guanine nucleotide-sensitive agonist binding. J. Neurochem. 58:628-635.
21. Shahrestanifar, M. S. and Howells, R. D. 1996. Sensitivity of opioid receptor binding to N-substituted maleimides and methanethiosulfonate derivatives. Neurochem. Res. 21:1295-1299.
22. Deng, H. B. and Weng, J. B. 1996. Cysteine residues in transmembrane domains of mu opiate receptor are involved in receptor binding. Society for Neuroscience 22:1766 (Abs).
23. 2 dopamine receptor is exposed in the binding-site crevice. Proc. Natl. Acad. Sci. USA 91:10355-10359.
24. Stauffer, D. A., and Karlin, A. 1994 The electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates. Biochem. 33, 6840-6849.
25. Akabas, M. H. Stauffer, D. A., Xu, M and Karlin, A. 1992. Acetylcholine receptor channel structure probed in cyteine-substitution mutants. Science 258:307-310.
26. Xu, M. and Akabas, M. H. 1993. Amino acids lining the channel of the γ-aminobutyric acid type A receptor identified by cysteine substitution. J. Biol. Chem. 268:21505-21508.
27. Akabas, M. H., Kaufmann, C., Cook, T. A., and Archdeacon, P. 1994. Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 269: 14865-14868.
28. Shahrestanifar, M., Wang, W. W. and Howells, R. D. 1996. Studies on inhibition of μ and δ opioid receptor binding by dithiothreitol and N-ethyhnaleimide. J. Biol. Chem. 271:5505-5512.
29. Giabelet, G., Capeyrou, R., Dietrich, G., and Emorine, L. J. 1997. Identification in the μ-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents. FEBS Lett. 408:135-140.